Solid lipid nanoparticles for ocular drug delivery

Drug Delivery

Volumn 17, Issue 7, 2010, Pages 467-489

  Seyfoddin, Ali ^a   Shaw, John ^a   Al Kassas, Raida ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Case studies; Colloidal drug delivery; Controlled release; Corneal penetration; Nanostructured lipid carriers

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; AGENTS ACTING ON THE EYE; ALPHA TOCOPHEROL; AMPHOTERICIN B; CREMOPHOR; CYCLOSPORIN; DICLOFENAC; DIETHYLENE GLYCOL MONOETHYL ETHER; DRUG CARRIER; EMULSIFYING AGENT; GELUCIRE; GENTAMICIN; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; GLYCEROL STEARATE; LIPID; MIGLYOL; NIOSOME; OCTADECYLAMINE; OIL; PACLITAXEL; PHOSPHATIDYLCHOLINE; SOLID LIPID NANOPARTICLE; STEARIC ACID; SURFACTANT; TOBRAMYCIN; TRIACYLGLYCEROL; TRIPALMITIN; UNINDEXED DRUG; WATER;

BIODEGRADABILITY; BLOOD EYE BARRIER; BLOOD RETINA BARRIER; CONTROLLED RELEASE FORMULATION; CORNEA; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG QUALITY; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; ENCAPSULATION; EVAPORATION; FREEZE DRYING; HUMAN; MICROEMULSION; MORPHOLOGY; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PURIFICATION; REVIEW; SPRAY DRYING; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; CHEMISTRY, PHARMACEUTICAL; CORNEA; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; LIPIDS; NANOPARTICLES; OPHTHALMIC SOLUTIONS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 77956161610     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.483257     Document Type: Review

References (110)

1. Abdelbary, G., El-Gendy, N. (2008). Niosome-encapsulated gen-tamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 9:740-747
2. Almeida, A.J., Runge, S., Müller, R.H. (1997). Peptide-loaded solid lipid nanoparticles (SLN): infuence of production parameters. Int J Pharm. 149:255-265
3. Almeida, A.J., Souto, E. (2007). Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 59:478-490
4. Alonso, M.J., Alonso, M.J. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother. 58:168-172
5. Araújo, J., Gonzalez, E., Egea, M.A., Garcia, M.L., Souto, E.B. (2009). Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine: NBM, 5:394-401.
6. Attama, A.A., Müller-Goymann, C.C. (2007). Investigation of surface-modifed solid lipid nanocontainers formulated with a heteroli-pid-templated homolipid. Int J Pharm. 334:179-189
7. Attama, A.A., Reichl, S., Müller-Goymann, C.C. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 355:307-313
8. Attama, A.A., Reichl, S., Muller-Goymann, C.C. (2009). Sustained release and permeation of timolol from surface-modifed solid lipid nanoparticles through bioengineered human cornea. Curr Eye Res. 34:698-705.
9. Attama, A.A., Schicke, B.C., Paepenmüller, T., Müller-Goymann, C.C. (2007). Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. Eur J Pharm Biopharm. 67:48-57.
10. Basaran, Ebru., Demirel, M., Sirmagul, B. and Yazan, Y. (2009). Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular drug delivery. J Microencapsul. 27:1-11.
11. Boisseau, P., Kiparissides, C., Pavesio, A., Saxl, O. (2005). European technology platform on nanoMedicine\nanotechnology for health, vision paper and basis for a strategic research agenda for nanomedicine. European Commission: Ofce for Ofcial Publications of the European Communities (Luxembourg), 39 pp. ISBN 92-79-02203-2 (keine IP).
12. Bottari, F., Giannaccini, B., Cristofori, B., Saettone, M.F., Tellini, N. (1978). Semisolid ophthalmic vehicles. I\A study of eye irritation in albino rabbits of a series of gel-type aqueous bases. Farmaco\Edizione Pratica. 33:434-446
13. Bourlais, C.L., Acar, L., Zia, H., Sado, P.A., Needham, T., Leverge, R. (1998). Ophthalmic drug delivery systems\recent advances. Prog Retin Eye Res. 17:33-58.
14. Bunjes, H., Koch, M.H.J. (2005). Saturated phospholipids promote crystallization but slow down polymorphic transitions in trig-lyceride nanoparticles. J Contr Rel. 107:229-243
15. Bunjes, H., Unruh, T. (2007). Characterization of lipid nanoparticles by diferential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 59:379-402.
16. Bunjes, H., Westesen, K., Koch, M.H.J. (1996). Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm. 129:159-173
17. Calvo, P., Tomas, C., Alonso, M.J., Vila Jato, J.L., Robinson, J. (1994). Study of the mechanism of interaction of poly-E-caprolactone with the cornea by confocal laser scanning microscopy. Int J Pharm. 103:283-291
18. Carafa, M., Santucci, E., Alhaique, F., Coviello, T., Murtas, E., Riccieri, F.M., Lucania, G., Torrisi, M.R. (1998). Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm. 160:51-59
19. Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S., Saettone, M.F. (2002). Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm. 238:241-245
20. Cavalli, R., Zara, G.P., Caputo, O., Bargoni, A., Fundarò, A., Gasco, M.R. (2000). Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I\a pharmacoki-netic study. Pharmacol Res. 42:541-545
21. Cavalli, R., Marengo, E., Rodriguez, L., Gascom, R. (1996). Efects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm. 43:110-115
22. Chen, M.-L. (2008). Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev. 60:768-777
23. Coleman, N.J., Craig, D.Q.M. (1996). Modulated temperature difer-ential scanning calorimetry: a novel approach to pharmaceutical thermal analysis. Int J Pharm. 135:13-29.
24. Cortesi, R., Argnani, R., Esposito, E., Dalpiaz, A., Scatturin, A., Bortolotti, F., Lufno, M., Guerrini, R., Cavicchioni, G., Incorvaia, C., Menegatti, E., Manservigi, R. (2006). Cationic lipo-somes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int J Pharm. 317:90-100.
25. Debbage, P. (2009). Targeted drugs and nanomedicine: present and future. Curr Pharm Des. 15:153-172
26. Del Pozo-Rodríguez, A., Delgado, D., Solinís, M.A., Gascón, A.R., Pedraz, J.L. (2008). Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafcking in RPE cells. Int J Pharm. 360:177-183
27. Domb, A.J. (1995). Long acting injectable oxytetracycline-liposphere formulations. Int J Pharm. 124:271-278
28. Draize, J.H., Woodard, G., Calvery, H.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Terapeut. 82:377-390
29. Duvvuri, S., Majumdar, S., Mitra, A.K. (2003). Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ter. 3:45-56.
30. Franz, T.J. (1975). Percutaneous absorption on the relevance of in vitro data. J Investig Dermatol. 64:190-195
31. ™). Eur J Pharm Biopharm. 46:145-151
32. ™) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 47:125-132
33. Gaudana, R., Jwala, J., Boddu, S.H., Mitra, A.K., Gaudana, R., Boddu, S.H.S., Mitra, A.K. (2009). Recent perspectives in ocular drug delivery. Pharm Res. 26:1197-1216
34. Gill, P.S., Sauerbrunn, S.R., Reading, M. (1993). Modulated diferential scanning calorimetry. J Term Anal Calorim. 40:931-939
35. Giunchedi, P., Conte, U., Chetoni, P., Saettone, M.F. (1999). Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits. Eur J Pharm Biopharm. 9:1-7.
36. Gokce, E.H., Sandri, G., Bonferoni, M.C., Rossi, S., Ferrari, F., Guneri, T., Caramella, C. (2008). Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm. 364:76-86.
37. Gokce, E.H., Sandri, G., Egrilmez, S., Bonferoni, M.C., Guneri, T., Caramella, C. (2009). Cyclosporine A-loaded solid lipid nano-particles: ocular tolerance and in vivo drug release in rabbit eyes. Curr Eye Res. 34:996-1003.
38. Hauss, D.J. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev. 59:667-676
39. Heiati, H., Tawashi, R., Phillips, N.C. (1998). Drug retention and stability of solid lipid nanoparticles containing azidothymi-dine palmitate after autoclaving, storage and lyophilization. J Microencapsul. 15:173-184
40. Heiati, H., Tawashi, R., Shivers, R.R., Phillips, N.C. (1997). Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3'-azido-3'-deoxythymidine palmitate. Int J Pharm. 146:123-131
41. Helgason, T., Awad, T.S., Kristbergsson, K., McClements, D.J., Weiss, J. (2009). Efect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci. 334:75-81.
42. Heydenreich, A.V., Westmeier, R., Pedersen, N., Poulsen, H.S., Kristensen, H.G. (2003). Preparation and purifcation of cationic solid lipid nanospheres\efects on particle size, physical stability and cell toxicity. Int J Pharm. 254:83-87
43. Hironaka, K., Inokuchi, Y., Tozuka, Y., Shimazawa, M., Hara, H., Takeuchi, H. (2009). Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Contr Rel. 136:247-253
44. Hornof, M., Toropainen, E., Urtti, A. (2005). Cell culture models of the ocular barriers. Eur J Pharm Biopharm. 60:207-225
45. Hou, D., Xie, C., Huang, K., Zhu, C. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 24:1781-1785
46. Hu, F.Q., Hong, Y., Yuan, H. (2004). Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm. 273:29-35.
47. Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., Zeng, S. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent difusion method in an aqueous system. Colloids Surf B Biointerfaces. 45:167-173
48. Hu, F.Q., Yuan, H., Zhang, H.H., Fang, M. (2002). Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent difusion method in aqueous system and physicochemical characterization. Int J Pharm. 239:121-128
49. Jannin, V., Musakhanian, J., Marchaud, D. (2008). Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 60:734-746
50. Janoria, K.G., Hariharan, S., Dasari, C.R., Mitra, A.K. (2007). Recent patents and advances in ophthalmic drug delivery. Recent Patents Drug Deliv Formul. 1:161-170
51. Jenning, V., Mäder, K., Gohla, S.H. (2000). Solid lipid nanoparticles (SLN(TM)) based on binary mixtures of liquid and solid lipids: a 1H-NMR study. Int J Pharm. 205:15-21.
52. Kaur, I.P., Garg, A., Singla, A.K., Aggarwal, D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 269:1-14.
53. Kaur, I.P., Kanwar, M., Kaur, I.P., Kanwar, M. (2002). Ocular preparations: the formulation approach. Drug Dev Ind Pharm. 28:473-493
54. Kaur, I.P., Rana, C., Singh, H. (2008). Development of efective ocular preparations of antifungal agents. J Ocul Pharmacol Terapeut. 24:481-493
55. Küchler, S., Radowski, R.M., Haag, R., Schäfer-Korting, M. (2008). Comparison of solid lipid nanoparticles and dendritic core-mul-tishell nanoparticles as drug delivery systems for topical application. European Workshop on Particulate Systems, Berlin.
56. Kuo, Y.-C., Chen, H.-H. (2009). Entrapment and release of saquina-vir using novel cationic solid lipid nanoparticles. Int J Pharm. 365:206-213
57. Law, S.L., Huang, K.J., Chiang, C.H. (2000). Acyclovir-containing liposomes for potential ocular delivery: corneal penetration and absorption. J Contr Rel. 63:135-140
58. Lherm, C., Müller, R.H., Puisieux, F., Couvreur, P. (1992). Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacr-ylate nanoparticles with diferent alkyl chain length. Int J Pharm. 84:13-22.
59. Li, X., Lin, X., Zheng, L., Yu, L., Lv, F., Zhang, Q., Liu, W. (2008a). Efect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly(ethylene glycol) stearate-modifed solid lipid nanoparticles. Colloid Surf Physicochem Eng Aspect. 317: 352-359
60. Li, X., Nie, S.-F., Kong, J., Li, N., Ju, C.-Y., Pan, W.-S. (2008b). A con-trolled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm. 363:177-182
61. Lin, X., Li, X., Zheng, L., Yu, L., Zhang, Q., Liu, W. (2007). Preparation and characterization of monocaprate nanostructured lipid carriers. Colloid Surf A Physicochem Eng Aspects. 311:106-111
62. Liu, X., Zhang, Y., Tang, X., Zhang, H. (2009). Determination of entrapment efciency and drug phase distribution of submicron emulsions loaded silybin. J Microencapsul. 26:180-186
63. Liu, Z., Pan, W., Nie, S., Zhang, L., Yang, X., Li, J. (2005). Preparation and evaluation of sustained ophthalmic gel of enoxacin. Drug Dev Ind Pharm. 31:969-975
64. Lv, Q., Yu, A., Xi, Y., Li, H., Song, Z., Cui, J., Cao, F., Zhai, G. (2009). Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 372:191-198
65. Mainardes, R.M., Urban, M.C.C., Cinto, P.O., Khalil, N.M., Chaud, M.V., Evangelista, R.C., Dafon Gremiao, M.P. (2005). Colloidal carriers for ophthalmic drug delivery. Curr Drug Target. 6:363-371
66. Marengo, E., Cavalli, R., Caputo, O., Rodriguez, L., Gasco, M.R. (2000). Scale-up of the preparation process of solid lipid nanospheres. Part I. Int J Pharm. 205:3-13.
67. Mehnert, W., Mäder, K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47:165-196
68. Meisner, D., Mezei, M. (1995). Liposome ocular delivery systems. Adv Drug Deliv Rev. 16:75-93.
69. Moshfeghi, A.A., Peyman, G.A. (2005). Micro-and nanoparticulates. Adv Drug Deliv Rev. 57:2047-2052
70. Müller, R.H., Lucks, J.S. (1996). Arzneistofträger aus festen Lipidteilchen-Feste Lipid Nanosphären (SLN), European patent EP 0 605 497 B1.
71. Müller, R.H., Mäder, K., Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery\a review of the state of the art. Eur J Pharm Biopharm. 50:161-177
72. Müller, R.H., Radtke, M., Wissing, S.A. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 242:121-128
73. Nagarwal, R.C., Kant, S., Singh, P.N., Maiti, P., Pandit, J.K. (2009). Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Contr Rel. 136:2-13.
74. Nilüfer, Y., Aysegül, K., Yalcin, O., Ayhan, S., Sibel, A.O., Tamer, B. (2003). Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol in vitro and in vivo evaluation. Eur J Pharm Biopharm. 56:453-459
75. Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R.H., Kneuer, C. (2001). Cationic solid-lipid nanoparticles can efciently bind and trans-fect plasmid DNA. J Contr Rel. 77:345-355
76. Pardeike, J., Hommoss, A., Müller, R. H. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 366:170-184
77. Pouton, C.W., Porter, C.J.H. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 60:625-637
78. Radomska-Soukharev, A. (2007). Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev. 59:411-418
79. Reichl, S., Bednarz, J., Muller-Goymann, C.C. (2004). Human corneal equivalent as cell culture model for in vitro drug permeation studies. B J Ophthalmol. 88:560-565
80. Reichl, S., Döhring, S., Bednarz, J., Müller-Goymann, C.C. (2005). Human cornea construct HCC\an alternative for in vitro permeation studies? A comparison with human donor corneas. Eur J Pharm Biopharm. 60:305-308
81. Ronald, D.S., Hong-Shian, H. (1983). Corneal penetration behavior of beta-blocking agents I: physicochemical factors. J Pharm Sci. 72:1266-1272
82. Sahoo, S.K., Dilnawaz, F., Krishnakumar, S. (2008). Nanotechnology in ocular drug delivery. Drug Discov Today. 13:144-151
83. Sawant, K.K., Dodiya, S.S. (2008). Recent advances and patents on solid lipid nanoparticles. Recent Patents Drug Deliv Formulation. 2:120-135
84. Schwarz, C., Mehnert, W. (1997). Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm. 157:171-179
85. Seal, D.V., Bron, A.J., Hay, J. (1998). Ocular infection; investigation and treatment in practice., London: Martin Dunitz Ltd.
86. Shen, J., Sun, M., Ping, Q., Ying, Z., Liu, W. (2010). Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Nanotechnology. 21:1-10.
87. Shen, J., Wang, Y., Ping, Q., Xiao, Y., Huang, X. (2009). Mucoadhesive efect of thiolated PEG stearate and its modifed NLC for ocular drug delivery. J Contr Rel. 137:217-223
88. Sjöström, B., Bergenståhl, B. (1992). Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm. 88:53-62.
89. ® ATO as bulk lipid and as SLN and NLC. J Microencapsul. 23:417-433
90. Souto, E.B., Wissing, S.A., Barbosa, C.M., Müller R.H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278:71-77
91. Trotta, M., Cavalli, R., Carlotti, M.E., Battaglia, L., Debernardi, F. (2005). Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-difusion technique. Int J Pharm. 288:281-288
92. Trotta, M., Debernardi, F., Caputo, O. (2003). Preparation of solid lipid nanoparticles by a solvent emulsifcation-difusion technique. Int J Pharm. 257:153-160
93. Uchegbu, I.F., Vyas, S.P. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 172:33-70.
94. Urtti, A. (2006). Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 58:1131-1135
95. Urtti, A., Salminen, L. (1993). Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 37:435-456
96. Vandamme, T.F. (2002). Microemulsions as ocular drug delivery systems: recent developments and future challenges. Progr Retin Eye Res. 21:15-34.
97. Velpandian, T., Velpandian, T. (2009). Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies. Expert Opin Drug Deliv. 6:255-270
98. Vighi, E., Ruozi, B., Montanari, M., Battini, R., Leo, E. (2007). Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm. 67:320-328
99. Vyas, S.P., Rai, S., Paliwal, R., Gupta, P.N., Khatri, K., Goyal, A.K., Vaidya, B. (2008). Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology. Curr Nanosci. 4:30-44.
100. Wadhwa, S., Paliwal, R., Paliwal, S.R., Vyas, S.P. (2009). Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 15:2724-2750
101. Westesen, K., Bunjes, H. (1995). Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm. 115:129-131
102. Westesen, K., Bunjes, H., Koch, M.H.J. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Contr Rel. 48:223-236
103. Westesen, K., Siekmann, B. (1997). Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm. 151:35-45.
104. Wissing, S.A., Kayser, O., Müller, R.H. (2004). Solid lipid nano-particles for parenteral drug delivery. Adv Drug Deliv Rev. 56:1257-1272
105. Yasukawa, T., Kimura, H., Tabata, Y., Ogura, Y. (2001). Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev. 52:25-36.
106. Yun, J., Zhang, S., Shen, S., Chen, Z., Yao, K., Chen, J. (2009). Continuous production of solid lipid nanoparticles by liquid fow-focusing and gas displacing method in microchannels. Chem Eng Sci. 64:4115-4122
107. Zhang, S.-H., Shen, S.-C., Chen, Z., Yun, J.-X., Yao, K.-J., Chen, B.-B., Chen, J.-Z. (2008). Preparation of solid lipid nanoparticles in co-fowing microchannels. Chem Eng Sci. 144:324-328
108. Zimmer, A., Kreuter, J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev. 16:61-73.
109. Zimmermann, E., Müller, R.H., Mäder, K. (2000). Infuence of diferent parameters on reconstitution of lyophilized SLN. Int J Pharm. 196:211-213
110. Zur Mühlen, A., Schwarz, C., Mehnert, W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery\drug release and release mechanism. Eur J Pharm Biopharm. 45: 149-155